0001171843-16-010709.txt : 20160616 0001171843-16-010709.hdr.sgml : 20160616 20160616163102 ACCESSION NUMBER: 0001171843-16-010709 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160331 FILED AS OF DATE: 20160616 DATE AS OF CHANGE: 20160616 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Sucampo Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001365216 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 133929237 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 805 KING FARM BOULEVARD, SUITE 550 CITY: ROCKVILLE STATE: MD ZIP: 20850 BUSINESS PHONE: 3019613400 MAIL ADDRESS: STREET 1: 805 KING FARM BOULEVARD, SUITE 550 CITY: ROCKVILLE STATE: MD ZIP: 20850 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Greenleaf Peter CENTRAL INDEX KEY: 0001363683 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33609 FILM NUMBER: 161717905 MAIL ADDRESS: STREET 1: ONE MEDIMMUNE WAY CITY: GAITHERSBURG STATE: MD ZIP: 20878 4 1 f4_061616greenleaf.xml OWNERSHIP DOCUMENT X0306 4 2016-03-31 0 0001365216 Sucampo Pharmaceuticals, Inc. SCMP 0001363683 Greenleaf Peter 805 KING FARM BLVD, SUITE 550 ROCKVILLE MD 20850 0 1 0 0 Chief Executive Officer Common Stock, Class A (ESPP) 2016-03-31 5 A 0 E 646 9.29 A 1122 D The reporting person is voluntarily reporting the acquisition of common stock pursuant to the issuer's Employee Stock Purchase Plan (ESPP) for the period January 1, 2016 through March 31, 2016. This transaction is exempt under Rule 16(b)-3(c). In accordance with the ESPP, these shares were purchased at 85% of the closing price of the issuer's common stock on March 31, 2016. /s/ Peter Greenleaf 2016-06-16